Contact Us
Drug Search Results
More Filters [+]

Alalevonadifloxacin

Alternative Names: alalevonadifloxacin, wck-2349, wck2349, wck 2349
Latest Update: 2024-04-01
Latest Update Note: PubMed Publication

Product Description

Alalevonadifloxacin (WCK 2349) is a novel l-alanine ester prodrug of levonadifloxacin that is being developed as an oral fluoroquinolone antibiotic. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/29263070/)

Mechanisms of Action: DNA Replication Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Wockhardt
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Alalevonadifloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Healthy Volunteers|Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
W-2349-102

P1

Completed

Healthy Volunteers

2014-12-01

W-2349-103

P1

Completed

Healthy Volunteers

2014-12-01

W-2349-101

P1

Completed

Other

2014-12-01

W 771/2349-101

P1

Completed

Healthy Volunteers

2013-06-01

Recent News Events

Date

Type

Title

04/01/2024

PubMed

 In Vitro Assessment of Antimicrobial Activity of Novel Fluoroquinolone, Levonadifloxacin (WCK 771) Against Multi-Drug-Resistant Clinical Isolates from Cancer Patients in India.

02/28/2024

PubMed

 Efficacy and Safety of Oral and IV Levonadifloxacin Therapy in Management of Bacterial Infections: Findings of a Prospective, Observational, Multi-center, Post-marketing Surveillance Study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions